Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab (Rituxivac)

This study has been completed.
Information provided by (Responsible Party):
M. Rab, St. Antonius Hospital Identifier:
First received: October 6, 2012
Last updated: January 30, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)